Issue link: https://viewer.e-digitaledition.com/i/42856
ON THE LEADING EDGE OF PATHOLOGY EVERY PHYSICIAN INVOLVED in cancer care knows the indispensable role played by pathology. St. Luke's Hospital & Health Network uses a system of synoptic reporting for pathology, which ensures the information needed by specialists along all points of the cancer care continuum is in one convenient location. "Synoptic reporting is a way of ensuring that for each cancer in each organ of the body, the facts required for thorough and defi nite treatment — as defi ned by consensus of the American College of Surgeons, College of American Pathologists and American Society of Clinical Oncology — are gathered in one place," says David W. Anderson, M.D., Ph.D., FCAP, Network Chief of Pathology for St. Luke's Hospital & Health Network. "Some aspects of cancer can't be found in a pathology report because they relate to the performance status of the individuals involved, which is really a clinician's purview, rather than a pathologist's. The advantages of synoptic reporting are that a surgeon, radia- tion oncologist or medical oncologist can pick up a pathologist's report and know where to fi nd everything he or she needs without having to search for it." Pathologists are some of the most important physicians involved in cancer care, as they perform microscopic analysis on samples to determine whether a patient has the disease. The system of internal concurring pathology helps remove some of the potential subjectivity from pronouncing a patient has cancer. "The more pathologists agree with the statement, 'This individual has cancer,' the more secure the diagnosis," Dr. Anderson says. "We feel so strongly that each new and recurrent cancer should be labeled as such only after at least two pathologists agree, that we have a real-time telepathology system between our campuses. If a pathologist at St. Luke's Hospital – Allentown Campus fi nds a new cancer at 3 p.m., for example, he or she can immediately seek my opinion or that of colleagues at other campuses. If the two pathologists agree, that's not the end of the conversation. They will go on to discuss what kind of cancer it could be and what additional tests are needed. Internal concurring pathol- ogy provides a mentoring opportunity for younger colleagues and a sharing opportunity for more experienced colleagues." Neil D. Belman, D.O. Jay S. Riccardi, M.D. Sanjiv S. Agarwala, M.D.. Nimisha Deb, M.D. David W. Anderson, M.D. Hugh D. Moulding, M.D., Ph.D. William R. Burfeind Jr., M.D. looking at a problem because there is always the possibility of another discipline having a positive impact on a patient's care. The Tumor Board provides a snapshot, whereas the Working Group is a kind of ongoing, continual review. As cancer patients live longer, it's more likely they'll be exposed to multiple modalities of treatment, so the Working Group is important because it allows us to use the right tools at the right time during a patient's journey with cancer." Exemplifying Our Multidisciplinary Culture The Lung Tumor Board, part of St. Luke's Comprehensive Lung Cancer Program, is another example of the vari- ous tumor boards that exist at St. Luke's Hospital & Health Network. Established in approximately 2004, the Lung Tumor Board includes everyone who has a stake in the care of the lung cancer patient: dedicated thoracic surgeons, medical oncologists, radiation oncologists, pul- monologists, pathologists, radiologists Lee B. Riley, M.D., Ph.D., FACS

